Search Publications

Publications

Pubmed ID Author Year Title

26503544

Techatraisak K

2016

Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.

26507097

Feng W

2016

Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.

26507209

Xirofotos D

2016

The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS.

26507336

Pacchiarotti A

2016

Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.

26508882

Nikokavoura EA

2015

Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.

26509855

Goodman NF

2015

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

26510685

Castro V

2015

Identification of subjects with polycystic ovary syndrome using electronic health records.

26510692

Arif M

2016

Implication of thymoquinone as a remedy for polycystic ovary in rat.

26511871

Yuan C

2015

Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome.

26512349

Han Y

2015

Metabolic effects of polycystic ovary syndrome in adolescents.

26514501

Sekar N

2015

Multi-Parameter Approach for Evaluation of Genomic Instability in the Polycystic Ovary Syndrome.

26514948

Yang HY

2015

The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.

26516311

Swaroop A

2015

Efficacy of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst) in Polycystic Ovary Syndrome (PCOS).

26517932

Prudente S

2015

The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations.

26519818

Song X

2015

Family association study between melatonin receptor gene polymorphisms and polycystic ovary syndrome in Han Chinese.

26520034

Schiavo L

2015

Sleeve gastrectomy to treat concomitant polycystyc ovary syndrome, insulin and leptin resistance in a 27-years morbidly obese woman unresponsive to insulin-sensitizing drugs: A 3-year follow-up.

26521485

Lai H

2015

[Mouse models of polycystic ovary syndrome].

26523627

Carmina E

2016

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.

26524825

Warenik-Szymankiewicz A

2015

Pregnancy after ovarian wedge resection in a polycystic ovarian patient after laparoscopic ovarian cauterization.

26525693

Gozukara IO

2016

Effect of colchicine on polycystic ovary syndrome: an experimental study.

26525695

Thanaboonyawat I

2016

The correlation of cumulus mucification patterns with oocyte maturation rate in vitro in FSH?+?LH-primed IVM cycles: a prospective study.

26527503

Fusi FM

2015

Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.

26534044

Eek D

2015

A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos).

26534154

Reaney M

2015

The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale.

26536002

Gammoh E

2015

Transcription Factor-7-Like 2 Gene Variants Affect the Metabolic Phenotypes of Polycystic Ovary Syndrome.

26539805

Shen XD

2016

Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.

26542642

Rubin KH

2016

Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study.

26542956

Detti L

2015

Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome.

26545724

Hughan KS

2016

Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

26545735

Arpaci D

2015

The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome.

26545973

Alviggi C

2016

The effect of FT500 Plus(?) on ovarian stimulation in PCOS women.

26548314

Day FR

2015

Shared genetic aetiology of puberty timing between sexes and with health-related outcomes.

26549181

Luque-Ram?rez M

2015

Targets to treat androgen excess in polycystic ovary syndrome.

26551442

Greenwood EA

2016

Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.

26551444

G?d?ny S

2015

[Evidence-based therapy of polycystic ovarian syndrome].

26553218

Trisno R

2016

Borderline personality disorder and polycystic ovary syndrome.

26553260

Zhao Y

2016

Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes.

26559558

Vaiarelli A

2016

Limited ability of circulating anti-M?llerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays.

26561543

Palomba S

2016

Pregnancy complications in women with polycystic ovary syndrome: importance of diagnostic criteria or of phenotypic features?

26561544

Kollmann M

2016

Reply: Maternal and neonatal outcomes in women diagnosed with PCOS by different definitions.

26563313

Seckin B

2016

Comparison of pregnancy rates in PCOS patients undergoing clomiphene citrate and IUI treatment with different leading follicular sizes.

26563606

Tehrani FR

2015

Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status?

26564281

Sharief M

2015

Comparison of letrazole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation.

26566413

Deveer M

2015

Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome.

26568133

Morris S

2016

What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.

26568493

Carmina E

2015

Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome.

26568749

Taghavi SA

2015

Health-related quality of life in polycystic ovary syndrome patients: A systematic review.

26569630

Huijgen NA

2015

Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?

26573528

Lee H

2016

A genetic risk score is associated with polycystic ovary syndrome-related traits.

26574894

Dupont J

2015

Adipokines in human reproduction.

26574952

Rees DA

2016

White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome.

26576288

Lange R

2015

Endocrine abnormalities in ring chromosome 11: a case report and review of the literature.

26577050

Mesbah F

2015

Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.

26578366

Gao L

2016

Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome.

26578565

Joseph S

2016

PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome.

26578781

Hu M

2015

Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring.

26582398

Sathyapalan T

2015

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.

26584566

Li H

2016

Free androgen index and Irisin in polycystic ovary syndrome.

26586671

Miranda-Furtado CL

2016

A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content.

26586837

Caanen MR

2016

Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.

26587805

Vinter CA

2016

Second Nordic Congress on Obesity in Gynecology and Obstetrics (NOCOGO).

26587847

Kogure GS

2016

Resistance Exercise Impacts Lean Muscle Mass in Women with Polycystic Ovary Syndrome.

26589554

Gao S

2016

The relationships of irisin with bone mineral density and body composition in PCOS patients.

26589977

Ayonrinde OT

2016

Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.

26592060

Asante A

2015

Screening for Insulin Resistance in Polycystic Ovary Syndrome: Views of Physician Members of the American Society for Reproductive Medicine.

26595150

Burchall GF

2016

Comprehensive Assessment of the Hemostatic System in Polycystic Ovarian Syndrome.

26595970

Razumov AN

2015

[The modern applications of radon therapy for the medical rehabilitation of the patients].

26597095

Palomba S

2016

Reply: Polycystic ovary syndrome and pregnancy.

26597569

Boothroyd C

2015

Consensus statement on prevention and detection of ovarian hyperstimulation syndrome.

26598450

Rosenfield RL

2015

The Diagnosis of Polycystic Ovary Syndrome in Adolescents.

26600064

Abu-Hijleh TM

2016

Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome.

26602525

Melo AS

2015

Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice.

26604210

Galazis N

2016

Polycystic ovary syndrome and pregnancy.

26605012

Motovali-Bashi M

2015

Association between Serum Paraoxonase 1 Activities (PONase/AREase) and L55M Polymorphism in Risk of Female Infertility.

26607017

Gao T

2016

Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis.

26608823

Chang AY

2016

Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study.

26611501

Rodino IS

2016

Obesity and psychological wellbeing in patients undergoing fertility treatment.

26613332

Alsaadi HM

2015

Insulin sensitivity affects corticolimbic brain responses to visual food cues in polycystic ovary syndrome patients.

26613790

Jamilian M

2016

The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.

26613820

El-khayat W

2016

A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate-resistant polycystic ovary syndrome.

26613823

Bhattacharya SM

2016

Comparison of two contraceptive pills containing drospirenone and 20 ?g or 30 ?g ethinyl estradiol for polycystic ovary syndrome.

26614265

Rosas C

2016

Hyperandrogenism Decreases GRP78 Protein Level and Glucose Uptake in Human Endometrial Stromal Cells.

26614851

Demirelli S

2015

The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.

26615047

St?por N

2015

[Insulin resistance in children].

26615602

Kyrkou G

2016

Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.

26616440

Yang Y

2016

Assessing new terminal body and facial hair growth during pregnancy: toward developing a simplified visual scoring system for hirsutism.

26617357

Karagiannidis I

2016

Endocrinologic Aspects of Hidradenitis Suppurativa.

26620588

Taghavi SA

2015

Health-related quality of life in Iranian women with polycystic ovary syndrome: a qualitative study.

26621011

Asemi Z

2015

Effects of Ramadan Fasting on Glucose Homeostasis, Lipid Profiles, Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome in Kashan, Iran.

26622314

Hossein Rashidi B

2015

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome.

26622481

Liu W

2015

Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome.

26622758

Liu W

2015

Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model.

26624567

Shah D

2016

Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?

26625974

Shaikh N

2016

Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.

26626234

Tannus S

2015

Treatment strategies for the infertile polycystic ovary syndrome patient.

26626581

Xu H

2016

Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study.

26626914

Paterakis TS

2014

Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

26627120

Provost MP

2016

Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry.

26631404

Artimani T

2016

Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS.

26634686

Barber TM

2015

Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.